ロード中...
Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients
Different highly effective interferon-free treatment options for chronic hepatitis C virus (HCV) infection are currently available. Pre-existence of resistance associated variants (RAVs) to direct antiviral agents (DAAs) reduces sustained virologic response (SVR) rates by 3–53% in hepatitis C virus...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4552686/ https://ncbi.nlm.nih.gov/pubmed/26317755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0134395 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|